Form 4 for FHTX Foghorn Therapeutics Inc.
Accepted 2021-08-23 00:00:00 ET · period of report 2021-08-20 · accession 0001562180-21-005521 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-23 | 2021-08-20 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | M - OptEx | $0.54 | +23.0K | 446.5K | +5% | +$12.4K |
| D | 2021-08-23 | 2021-08-20 | FHTX | GOTTSCHALK ADRIAN | CEO, Dir | M - OptEx | $0.00 | -23.0K | 458.9K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-20 | M | A | 23,000 | $0.54 | 446,479 | D | — | — | |
| 2 | Derivative | Stock Options (Right to buy) | 2021-08-20 | M | D | 23,000 | $0.00 | 458,925 | D | $0.54 · — to 2027-05-29 | 23,000 Common Stock | (F2) The option vested as to 25% of the underlying shares of common stock on May 30, 2018, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. |